Skip to main content
  1. New Modalities
    • New Modalities
    Investigating how oligonucleotide-based therapies can boost immune response and improve checkpoint i ...
  2. Drug Delivery
    • Drug Delivery
    1. PK/PD Modeling and Simulation: Highlight the importance of pharmacokinetic (PK) and pharmacodynam ...
  3. Oligonucleotide Discovery
    • Oligonucleotide Discovery
  4. CMC & Process Development
    • CMC & Process Development
    Aligning analytical workflows with FDA/EMA requirements, ensuring robust impurity profiling, and val ...
  5. Drug Delivery
    • Drug Delivery

    Nostrum Bio

  6. Oligonucleotide Discovery
    • Oligonucleotide Discovery

    ChemGenes

    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    Afternoon Refreshments
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    1-2-1 Meetings/Networking Break
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    Evening Drinks Reception
  7. New Modalities
    • New Modalities
  8. CMC & Process Development
    • CMC & Process Development

    ChemGenes

  9. Oligonucleotide Discovery
    • Oligonucleotide Discovery
    Oligonucleotide therapeutics purification relies heavily on preparative-scale chromatography. Revers ...

    DuPont

    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    1-2-1 Meetings/Networking Break
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    Opening Address & Keynote Presentation:
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    Networking Lunch
  10. Drug Delivery
    • Drug Delivery

    Nitto-Avecia

  11. New Modalities
    • New Modalities
    Exploring new platforms such as DNAzymes, aptamers, and circular RNAs for enhanced stability and fun ...
  12. CMC & Process Development
    • CMC & Process Development
    Optimizing process characterization and scalability  by addressing purification, yield, and consiste ...
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    Morning Refreshments
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    1-2-1 Meetings/Networking Break
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    1-2-1 Meetings/Networking Break
  13. Oligonucleotide Discovery
    • Oligonucleotide Discovery
    • Oligonucleotide Discovery
    • Drug Delivery
    • CMC & Process Development
    • New Modalities
    Registration
  14. New Modalities
    • New Modalities
    Lessons from approved oligonucleotide therapies (e.g., for SMA and DMD) and their potential in cardi ...
  15. Drug Delivery
    • Drug Delivery
  16. CMC & Process Development
    • CMC & Process Development
    Navigating evolving requirements in the US and Europe, including release testing, characterization, ...